Next 10 |
home / stock / pclof / pclof news
2024-04-10 08:21:15 ET More on PharmaCielo Financial information for PharmaCielo Read the full article on Seeking Alpha For further details see: PharmaCielo signs binding letter of intent to acquire operations in Thailand
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...
2024-03-27 17:08:02 ET CEO of PharmaCielo, David Attard speaks to shareholders about the short seller report In early March, Hindenburg Research issued a short seller report targeting PharmaCielo's credibility and its stock. Moreover, the Company believes that this report represen...
2024-03-27 17:08:02 ET A Canadian company with Colombian operations PharmaCielo is a global company, headquartered in Canada. They are focusing on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related produ...
Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia ...
Austin, Texas and Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - January 4, 2024) - Benuvia Operations, LLC ("Benuvia"), a FDA registered, DEA licensed and cGMP certified leader in pharmaceutical cannabinoids, and PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"), the Canad...
2023-11-29 10:23:36 ET More on PharmaCielo Financial information for PharmaCielo For further details see: PharmaCielo GAAP EPS of -C$0.02, revenue of C$352M
All figures in Canadian dollars ($) unless otherwise specified Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) (" PharmaCielo " or the " Company "), the Canadian parent of Colombia's premier cultivator and producer o...
Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000. The Company also announced that it has agreed to issue shares and debt in settlement of certain amounts owing. Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - October 6, 2023)...
2023-08-29 10:19:09 ET PharmaCielo press release ( OTCPK:PCLOF ): Q2 GAAP EPS of -C$0.02. Revenue of C$160,000 vs C$2.12M a year ago. For further details see: PharmaCielo GAAP EPS of -C$0.02
News, Short Squeeze, Breakout and More Instantly...
PharmaCielo Ltd. Company Name:
PCLOF Stock Symbol:
OTCMKTS Market:
PharmaCielo Ltd. (TSXV:PCLO) (OTCQX:PCLOF) revealed its plans to acquire cannabis operations in Thailand. What Happened On Wednesday, the Canadian ...
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...
2024-03-27 17:08:02 ET CEO of PharmaCielo, David Attard speaks to shareholders about the short seller report In early March, Hindenburg Research issued a short seller report targeting PharmaCielo's credibility and its stock. Moreover, the Company believes that this report represen...